Health systems around the world were recently brought into the spotlight due to COVID-19. The pandemic showed the strengths and weaknesses of different health systems and demonstrated the importance of efficient health systems in promoting and maintaining the health of a population. The long-term impact of the global outbreak remains to be seen, but it is clear the pandemic revealed flaws in health systems. Changes to funding, organization, and institutions may end up being a positive result of a terrible event.
FCL Industry Coverage
- Devices & Supplies
- Technology Systems
- Pharmaceutical & Biotechnology
Deal activity in the first half of 2021 was 27.5% higher than the same period last year with 6,716 closed transactions. Q2 volume slightly dropped from 3,424 to 3,292 deals as the backlog caused by the pandemic starts to normalize. Similar to other industries, IPOs in the sector also enjoyed a record high of 159 transactions in Q2 2021, which was more than 4x the volume during Q1 2020.